USM104

USM104 is a research-stage therapeutic candidate being developed by Uscare Pharm for the treatment of hair loss. It is categorized within the company's "Material Innovation" pipeline, which focuses on the discovery and development of novel bioactive materials for dermatological and aesthetic applications. As of 2024, the program is in the early research phase, and specific details regarding its chemical structure, molecular target, or mechanism of action have not been publicly disclosed. The development of USM104 is part of Uscare Pharm's broader effort to innovate in the field of hair regrowth and scalp health through the identification of functional materials.